STXSMEDIUM SIGNALFINANCIAL10-K

STXS shows mixed financial performance with significant equity improvement and revenue growth offset by deteriorating cash flow operations.

The 122% increase in stockholders' equity and 17% gross profit growth indicate improving financial health and operational performance. However, the 61% deterioration in operating cash flow suggests potential working capital management challenges or timing issues that warrant investor monitoring.

Comparing 2026-03-12 vs 2025-03-14View on EDGAR →
FINANCIAL ANALYSIS

The company demonstrates strong balance sheet improvement with stockholders' equity more than doubling to $13.5M and total assets growing 12% to $52.3M, while accounts receivable increased 53% signaling higher sales activity. Revenue growth is evident from the 17% increase in gross profit and 11% improvement in operating losses, though interest expense dropped dramatically by 91%. However, operating cash flow deteriorated significantly by 61% to -$13.7M, suggesting potential working capital pressures or collection issues despite the revenue growth.

FINANCIAL STATEMENT CHANGES
Stockholders Equity
Balance Sheet
+121.7%
$6.1M$13.5M

Equity base grew 121.7% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Interest Expense
P&L
-90.8%
$180K$17K

Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.

Operating Cash Flow
Cash Flow
-61.1%
-$8.5M-$13.7M

Operating cash flow fell 61.1% — earnings quality concerns; investigate working capital changes and non-cash items.

Accounts Receivable
Balance Sheet
+52.9%
$3.8M$5.8M

Receivables surged 52.9% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.

Current Assets
Balance Sheet
+28%
$26.4M$33.8M

Current assets grew 28% — improving short-term liquidity or inventory/receivables build.

Gross Profit
P&L
+17%
$14.6M$17.1M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Inventory
Balance Sheet
+14.8%
$8.3M$9.6M

Inventory built 14.8% — monitor whether demand supports this build or if write-downs may follow.

Total Assets
Balance Sheet
+11.8%
$46.7M$52.3M

Asset base grew 11.8% — expansion through organic growth, acquisitions, or capital deployment.

Operating Income
P&L
+10.6%
-$24.7M-$22.1M

Operating income improving — cost discipline or growing revenue base absorbing fixed costs.

LANGUAGE CHANGES
NEW — 2026-03-12
PRIOR — 2025-03-14
ADDED
The number of outstanding shares of the registrant s common stock on February 28, 2026, was 97,248,936 .
GenesisX RMN , Genesis RMN , Niobe , Navigant , Synchrony , SynX , Odyssey , Odyssey Cinema , MAGiC , MAGiC Sweep , EMAGIN , Map-iT , QuikCAS , Cardiodrive , Vdrive , Vdrive Duo , V-CAS , V-Loop , V-Sono , and NuVizion are trademarks of Stereotaxis, Inc.
Our primary products include the Genesis RMN and the GenesisX RMN Systems, the Odyssey and Synchrony SynX Solutions, various interventional devices under the Map-iT , MAGiC and EMAGIN brands, and other related devices.
The Genesis RMN and the GenesisX RMN Systems are designed to enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
The system also features a remote viewing and recording capability called Odyssey Cinema .
+7 more — sign up free →
REMOVED
The number of outstanding shares of the registrant s common stock on February 28, 2025, was 85,979,662 .
GenesisX RMN, Genesis RMN , Niobe , Navigant , Synchrony, SynX, Odyssey , Odyssey Cinema , MAGiC , EMAGIN, Map-iT , QuikCAS , Cardiodrive , Vdrive , Vdrive Duo , V-CAS , V-Loop , V-Sono , and NuVizion are trademarks of Stereotaxis, Inc.
Our primary products include the Genesis RMN System, the GenesisX RMN System , the Odyssey Solution, and other related devices.
The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
The system also features a remote viewing and recording capability called Odyssey Cinema, which is an innovative solution that delivers synchronized content for optimized workflow, advanced care, and improved productivity.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →